This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$39.62
US$ Class I Dist
NAV per share 08.04.2021
£960mAUM

AUM 26.02.2021

Holdings
72.52% Active Share
As at 26.02.2021